Literature DB >> 23923084

Dedifferentiated endometrial cancer: an atypical case diagnosed from cerebellar and adrenal metastasis: case presentation and review of literature.

Roberto Berretta1, Tito Silvio Patrelli, Raffaele Faioli, Daniele Mautone, Salvatore Gizzo, Antonio Mezzogiorno, Giovanna Giordano, Alberto Bacchi Modena.   

Abstract

Dedifferentiated endometrial cancer (DEC) is microscopically characterized by the presence of high-grade areas emerging from low-grade tumour. DEC is an aggressive tumour even when the dedifferentiated component represents only 20% of the entire neoplasm. A proper histological diagnosis is essential to define the most appropriate therapeutic approach for these tumors, since they are characterized by a particularly aggressive trend and by an extremely poor prognosis. We report a single case of DEC associated with dedifferentiated and adrenal metastasis, for which the patient underwent both abdominal-pelvic and cerebellar surgery. Dedifferentiated carcinoma of the endometrium is a poorly recognized neoplasm since they have not been clearly defined the histological features discriminating this neoplasm from high-grade endometrioid adenocarcinoma. Revising existing literature we found 79 described cases of central nervous system secondary involvement and 13 cases where the onset of the disease was characterized by neurological signs and symptoms. We could only find two reported cases of adrenal metastases originating from endometrial neoplasia but in no case of dedifferentiated endometrial carcinoma previously described has been reported the concomitant adrenal-cerebellar involvement.

Entities:  

Keywords:  Endometrial cancer; adrenal metastasis; cerebellum metastasis; dedifferentiated features; differential diagnosis

Mesh:

Year:  2013        PMID: 23923084      PMCID: PMC3726982     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

1.  Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

Authors:  Elvio G Silva; Michael T Deavers; Diane C Bodurka; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2006-01       Impact factor: 2.762

2.  Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups.

Authors:  K R Mittal; P E Schwartz; K W Barwick
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

3.  Central nervous system involvement from malignant mixed Müllerian tumor (MMMT) of the uterus.

Authors:  Anne Lihau N'Kanza; Sanjay Jobanputra; Peter Farmer; John Lovecchio; Jay A Yelon; Udo Rudloff
Journal:  Arch Gynecol Obstet       Date:  2005-10-28       Impact factor: 2.344

4.  Brain metastases from endometrial carcinoma.

Authors:  G Cormio; A Lissoni; G Losa; G Zanetta; A Pellegrino; C Mangioni
Journal:  Gynecol Oncol       Date:  1996-04       Impact factor: 5.482

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

Review 6.  Pathologic indicators of prognosis in endometrial adenocarcinoma. Selected aspects emphasizing the GOG experience. Gynecologic Oncology Group.

Authors:  R J Zaino
Journal:  Pathol Annu       Date:  1995

7.  Undifferentiated carcinoma of the endometrium.

Authors:  Basel Altrabulsi; Anais Malpica; Michael T Deavers; Diane C Bodurka; Russell Broaddus; Elvio G Silva
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

8.  The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma.

Authors:  A Ayhan; C Taskiran; K Yuce; T Kucukali
Journal:  Int J Gynecol Pathol       Date:  2003-01       Impact factor: 2.762

Review 9.  Undifferentiated carcinoma of the endometrium: a review.

Authors:  Elvio G Silva; Michael T Deavers; Anais Malpica
Journal:  Pathology       Date:  2007-02       Impact factor: 5.306

10.  The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Authors:  R J Zaino; S G Silverberg; H J Norris; B N Bundy; C P Morrow; T Okagaki
Journal:  Int J Gynecol Pathol       Date:  1994-01       Impact factor: 2.762

View more
  10 in total

1.  Dedifferentiated endometrial carcinoma: A report of three cases and review of the literature.

Authors:  Ryo Yokomizo; Kyosuke Yamada; Yasushi Iida; Takako Kiyokawa; Kazu Ueda; Motoaki Saito; Nozomu Yanaihara; Mayo Nakamura; Aikou Okamoto
Journal:  Mol Clin Oncol       Date:  2017-10-03

2.  Coexistence of adenomyosis and endometrioid endometrial cancer: Role in surgical guidance and prognosis estimation.

Authors:  Salvatore Gizzo; Tito Silvio Patrelli; Andrea Dall'asta; Stefania DI Gangi; Giovanna Giordano; Costanza Migliavacca; Michela Monica; Carla Merisio; Giovanni Battista Nardelli; Michela Quaranta; Marco Noventa; Roberto Berretta
Journal:  Oncol Lett       Date:  2015-12-15       Impact factor: 2.967

3.  Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.

Authors:  Andrea Dall'Asta; Salvatore Gizzo; Andrea Musarò; Michela Quaranta; Marco Noventa; Costanza Migliavacca; Giulio Sozzi; Michela Monica; Daniele Mautone; Roberto Berretta
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Quality of life in patients affected by endometrial cancer: comparison among laparotomy, laparoscopy and vaginal approach.

Authors:  Roberto Berretta; Salvatore Gizzo; Marco Noventa; Vivienne Marrazzo; Laura Franchi; Costanza Migliavacca; Monica Michela; Carla Merisio; Alberto Bacchi Modena; Tito Silvio Patrelli
Journal:  Pathol Oncol Res       Date:  2015-01-10       Impact factor: 3.201

5.  Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.

Authors:  Mackenzie Coatham; Xiaodong Li; Anthony N Karnezis; Lien N Hoang; Basile Tessier-Cloutier; Bo Meng; Robert A Soslow; C Blake Gilks; David G Huntsman; Colin J R Stewart; Lynne M Postovit; Martin Köbel; Cheng-Han Lee
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

6.  Intraperitoneal solitary fibrous tumor.

Authors:  Youssef Benabdejlil; Jaouad Kouach; Abdellah Babahabib; Moulay Elmehdi Elhassani; Issam Rharassi; Adil Boudhas; Hicham Bakkali; Mohammed Elmarjany; Driss Moussaoui; Mohamed Dehayni
Journal:  Case Rep Obstet Gynecol       Date:  2014-09-07

7.  Dedifferentiated endometrioid carcinoma of the uterus : report of four cases and review of literature.

Authors:  Jiheun Han; Eun Young Ki; Sung Eun Rha; SooYoung Hur; Ahwon Lee
Journal:  World J Surg Oncol       Date:  2017-01-10       Impact factor: 2.754

8.  Adrenal metastasis from endometrial cancer: A case report.

Authors:  Gianfranco Da Dalt; Alberto Friziero; Andrea Grego; Simone Serafini; Ambrogio Fassina; Stella Blandamura; Cosimo Sperti
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

9.  Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases

Authors:  Seyran Yiğit; Neşe Ekinci; Leyla Hayrullah; İrfan Öcal; İncim Bezircioğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-03-16

10.  Two Cases of Dedifferentiated Endometrioid Carcinoma: Case Presentation and Brief Review of the Literature.

Authors:  Sachiko Morioka; Yasuhito Tanase; Ryuji Kawaguchi; Tomoko Uchiyama; Hiroshi Kobayash
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.